{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:24:43Z","timestamp":1760239483077,"version":"build-2065373602"},"reference-count":49,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Introduction: The immunosuppressive effect of the disease and the applied treatment in children with juvenile idiopathic arthritis increases the risk of infections. It is therefore essential that vaccinations be properly implemented and that a proper serological response is provoked after the vaccination. A competent nurse acting in compliance with the current recommendations constitutes one of the safety pillars of immunization of pediatric patients with juvenile idiopathic arthritis. Aim: To discuss evidence-based recommendations for immunization of pediatric patients with juvenile idiopathic arthritis in the context of nursing vaccination practice and vaccinology education. Material and Methods: A systematic review of the literature presenting evidence-based recommendations of the European League Against Rheumatism (EULAR) expert group on immunization of children with juvenile idiopathic arthritis. Compilation of source data selected subjectively by the authors in a standard literature search of Medline, Cochrane and Scopus databases, including both recommendations for immunization of children with juvenile idiopathic arthritis and the tasks to be performed by nurses in the course of vaccine administration. As part of the standard literature review of Medline, Cochrane and Scopus databases, including both recommendations for immunization of children with juvenile idiopathic arthritis and the tasks to be performed by nurses in the course of vaccine administration. Results: Most vaccines are immunogenic and safe for patients with juvenile idiopathic arthritis. The use of attenuated vaccines in patients receiving long-term immunosuppressive treatment should be considered with particular caution. Education and further training of nurses should take into account the recommendations and principles of immunization regarding children with juvenile idiopathic arthritis. Nurses should present the current knowledge of active immunoprophylaxis in such a way as to encourage parents\/guardians to vaccinate their children in accordance with the national guidelines. Conclusion: The recommendations of the European League Against Rheumatism place special emphasis on the use of active immunoprophylaxis in the form of vaccination in children with juvenile idiopathic arthritis. The immunization schedule must be adjusted to the applied JIA treatment regimen. Such a stance on this matter is highly important as treatment regimens increasingly include biological drugs. Correctly performed by a nurse, a vaccination procedure is an important determinant of the desired immunoprophylactic results and minimizes the risk of adverse events following immunization. The priority for a nurse who provides active immunoprophylaxis should be to systematically broaden her training in immunization of chronically ill children, including juvenile idiopathic arthritis.<\/jats:p>","DOI":"10.3390\/jcm9113736","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T11:50:34Z","timestamp":1606132234000},"page":"3736","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vaccinology Education of Nurses and the Current Immunoprophylaxis Recommendations for Children with Juvenile Idiopathic Arthritis"],"prefix":"10.3390","volume":"9","author":[{"given":"Anna","family":"Bednarek","sequence":"first","affiliation":[{"name":"Department of Paediatric Nursing, Faculty of Health Sciences, Medical University of Lublin, 20059 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Klepacz","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathomorphology, Medical University of Lublin, 20059 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/BOR.0000000000000206","article-title":"Advances in the treatment of polyarticular juvenile idiopathic arthritis","volume":"27","author":"Webb","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2014.212","article-title":"Management of juvenile idiopathic arthritis: Hitting the target","volume":"11","author":"Hinze","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jbspin.2013.09.003","article-title":"Prevalence and incidence of juvenile idiopathic arthritis: A systematic review","volume":"81","author":"Thierry","year":"2014","journal-title":"Jt. Bone Spine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12969-017-0161-5","article-title":"A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: Challenges and opportunities","volume":"15","author":"Beukelman","year":"2017","journal-title":"Pediatr. Rheumatol."},{"key":"ref_5","first-page":"S67","article-title":"Infections and treatment of patients with rheumatic diseases","volume":"26","author":"Atzeni","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: What is the evidence?","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2011.150193","article-title":"EULAR recommendations for vaccination in paediatric patients with rheumatic diseases","volume":"70","author":"Heijstek","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1542\/peds.111.3.653","article-title":"Addressing parents\u2019 concerns: Do vaccines cause allergic or autoimmune diseases?","volume":"111","author":"Offit","year":"2003","journal-title":"Pediatrics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1016\/j.vaccine.2005.03.005","article-title":"Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines","volume":"23","author":"Schattner","year":"2005","journal-title":"Vaccine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/jaut.2000.0491","article-title":"Epidemiology of Autoimmune Reactions Induced by Vaccination","volume":"16","author":"Chen","year":"2001","journal-title":"J. Autoimmun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/08916930500050277","article-title":"Infection, vaccines and other environmental triggers of autoimmunity","volume":"38","author":"Molina","year":"2005","journal-title":"Autoimmunity"},{"key":"ref_12","first-page":"1","article-title":"Update: Vaccine side effects, adverse reactions, contraindications, and precautions recommendations of the advisory committee on immunization practices (ACIP)","volume":"45","author":"Washington","year":"1996","journal-title":"MMWR Recomm. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jaut.1999.0346","article-title":"Vaccination and autoimmunity \u2018vaccinosis\u2019: A dangerous liaison?","volume":"14","author":"Shoenfeld","year":"2000","journal-title":"J. Autoimmun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/ard.2004.023697","article-title":"EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees","volume":"63","author":"Dougados","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"ref_15","first-page":"351","article-title":"Vaccination practice in children with rheumatic disease","volume":"50","author":"Carvalho","year":"2010","journal-title":"Rev. Bras. Reum."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-015-0519-y","article-title":"Vaccinations in Paediatric Rheumatology: An Update on Current Developments","volume":"17","author":"Groot","year":"2015","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.vaccine.2020.01.037","article-title":"Live attenuated MMR\/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection","volume":"38","author":"Uziel","year":"2020","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.autrev.2008.11.002","article-title":"Serious infections during anti-TNF-alpha treatment in rheumatoid arthritis patients","volume":"8","author":"Favalli","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/rheumatology\/kel366","article-title":"Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients","volume":"46","author":"Kapetanovic","year":"2006","journal-title":"Rheumatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/ard.2003.013201","article-title":"Hepatitis B vaccination in children with juvenile idiopathic arthritis","volume":"63","author":"Kasapcopur","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"ref_21","first-page":"589","article-title":"Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy","volume":"19","author":"Trachana","year":"2001","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_22","first-page":"272","article-title":"Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab","volume":"34","author":"Kaine","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_23","first-page":"952","article-title":"Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone","volume":"34","author":"Visvanathan","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_24","first-page":"339","article-title":"Immune response to influenza vaccine in patients during the treatment with tocilizumab\u2014Comparison with conventional DMARDS and TNF inhibitors (abstract)","volume":"67","author":"Tsuru","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1002\/art.23059","article-title":"Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open-label extension analysis","volume":"56","author":"Keystone","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.25034","article-title":"Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial","volume":"62","author":"Bingham","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/s10165-012-0595-z","article-title":"Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab","volume":"22","author":"Shinoki","year":"2012","journal-title":"Mod. Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1136\/ard.2007.071878","article-title":"Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab","volume":"66","author":"Gelinck","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.25033","article-title":"Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab","volume":"62","author":"Holvast","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar3047","article-title":"Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment","volume":"12","author":"Rehnberg","year":"2010","journal-title":"Arthritis Res. Ther."},{"doi-asserted-by":"crossref","unstructured":"Tay, L., Le\u00f3n, F., Vratsanos, G., Raymond, R., and Corbo, M. (2007). Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: A randomized, open-label, parallel group study in healthy subjects. Arthritis Res. Ther., 9.","key":"ref_31","DOI":"10.1186\/ar2174"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-144-12-200606200-00003","article-title":"Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis","volume":"144","author":"Kremer","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.38092","article-title":"2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications","volume":"65","author":"Ringold","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/art.27431","article-title":"Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis","volume":"62","author":"Ruperto","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_35","first-page":"1","article-title":"General recommendations on immuni-zation: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Kroger","year":"2006","journal-title":"MMWR Recomm. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/INF.0b013e3181f7ce44","article-title":"Immunogenicity of Influenza Vaccine in Children with Pediatric Rheumatic Diseases Receiving Immunosuppressive Agents","volume":"30","author":"Ogimi","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_37","first-page":"20","article-title":"Safety and immunogenicity of a combined vaccine against hepatitis A and B in patients with autoimmune hepatitis","volume":"13","author":"Beran","year":"2005","journal-title":"Central Eur. J. Public Health"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.22399","article-title":"Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis","volume":"56","author":"Ronaghy","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/rheumatology\/ken436","article-title":"Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept","volume":"48","author":"Borte","year":"2009","journal-title":"Rheumatology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/ard.2006.063586","article-title":"Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis","volume":"66","author":"Heijstek","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patiens with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","article-title":"Pediatric Rheumatology Collaborative Study Group Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis","volume":"58","author":"Lovell","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10067-006-0441-9","article-title":"Infection-related morbidity and mortality in patients with connective tissue diseases: A systematic review","volume":"26","author":"Falagas","year":"2006","journal-title":"Clin. Rheumatol."},{"key":"ref_44","first-page":"139","article-title":"Immunization errors reported to a vaccine advice service: Intelligence to improve practice","volume":"22","author":"Lang","year":"2014","journal-title":"Qual. Prim. Care"},{"doi-asserted-by":"crossref","unstructured":"Committee on Infectious Diseases, and American Academy of Pediatrics (2009). Prevention of Rotavirus Disease: Updated Guidelines for Use of Rotavirus Vaccine. Pediatrics, 123, 1412\u20131420.","key":"ref_45","DOI":"10.1542\/peds.2009-0466"},{"doi-asserted-by":"crossref","unstructured":"K\u00fc\u00e7\u00fcko\u011flu, S., \u00c7elebio\u011flu, A., Caner, I., Ok, G., and Maden, R. (2015). The Effects of Instrumental Touching on Infant Pain Perception and the Effects of Eutectic Mixture of Local Anesthetics (EMLA) on the Reduction of Pain. Iran. J. Pediatr., 25.","key":"ref_46","DOI":"10.5812\/ijp.25(3)2015.532"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e581","DOI":"10.1542\/peds.2010-1886","article-title":"Injection Site and Risk of Medically Attended Local Reactions to Acellular Pertussis Vaccine","volume":"127","author":"Jackson","year":"2011","journal-title":"Pediatrics"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1016\/j.vaccine.2009.04.005","article-title":"Pediatric vaccination errors: Application of the \u201c5 Rights\u201d framework to a national error reporting database","volume":"27","author":"Bundy","year":"2009","journal-title":"Vaccine"},{"key":"ref_49","first-page":"194","article-title":"2016 update of the Portuguese recommendations for the use of biological therapies in children and adolescents with Juvenile Idiopathic Arthritis","volume":"41","author":"Santos","year":"2016","journal-title":"Acta Reum. Port."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/11\/3736\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:35:10Z","timestamp":1760178910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/11\/3736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["jcm9113736"],"URL":"https:\/\/doi.org\/10.3390\/jcm9113736","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2020,11,20]]}}}